Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Zanubrutinib
Obinutuzumab
UpToDate
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients